Literature DB >> 18254056

Full-mouth disinfection for the treatment of adult chronic periodontitis.

J Eberhard1, S Jepsen, P-M Jervøe-Storm, I Needleman, H V Worthington.   

Abstract

BACKGROUND: In an attempt to enhance treatment outcomes, alternative protocols for anti-infective periodontal therapy have been introduced.
OBJECTIVES: To evaluate the effectiveness of full-mouth disinfection or full-mouth scaling compared to conventional quadrant scaling for periodontitis. SEARCH STRATEGY: Data sources included electronic databases, handsearched journals and contact with experts. The Cochrane Oral Health Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and EMBASE were searched. Reference lists from relevant articles were scanned and the authors of eligible studies were contacted to identify trials and obtain additional information. Date of most recent searches: December 2006: (CENTRAL) (The Cochrane Library 2006, Issue 4). SELECTION CRITERIA: Randomised controlled trials were selected with at least 3 months follow up comparing full-mouth scaling and root planing within 24 hours with (FMD) or without (FMS) the adjunctive use of an antiseptic (chlorhexidine) with conventional quadrant scaling and root planing (control). The methodological quality of the studies was assessed within the data extraction form, mainly focusing on: method of randomisation, allocation concealment, blindness of examiners and completeness of follow up. DATA COLLECTION AND ANALYSIS: Data extraction and quality assessment were conducted independently by multiple review authors. The primary outcome measure was tooth loss, secondary outcomes were reduction of probing depth, bleeding on probing and gain in probing attachment. The Cochrane Collaboration statistical guidelines were followed. MAIN
RESULTS: The search identified 216 abstracts. Review of these abstracts resulted in 12 publications for detailed review. Finally, seven randomised controlled trials (RCTs) which met the criteria for eligibility were independently selected by two review authors. None of the studies included reported on tooth loss. All treatment modalities led to significant improvements in clinical parameters after a follow up of at least 3 months. For the secondary outcome, reduction in probing depth, the mean difference between FMD and control was 0.53 mm (95% confidence interval (CI) 0.28 to 0.77) in moderately deep pockets of single rooted teeth and for gain in probing attachment 0.33 mm (95% CI 0.04 to 0.62) in moderately deep single and multirooted teeth. Comparing FMD and FMS the mean difference in one study for gain in probing attachment amounted to 0.74 mm in favour of FMS (95% CI 0.17 to 1.31) for deep pockets in multirooted teeth, while another study reported a mean difference for reduction in bleeding on probing of 18% in favour of FMD (95% CI -33.74 to -2.26) for deep pockets of single rooted teeth. No significant differences were observed for any of the outcome measures, when comparing FMS and control. AUTHORS'
CONCLUSIONS: In patients with chronic periodontitis in moderately deep pockets slightly more favourable outcomes for pocket reduction and gain in probing attachment were found following FMD compared to control. However, these additional improvements were only modest and there was only a very limited number of studies available for comparison, thus limiting general conclusions about the clinical benefit of full-mouth disinfection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18254056     DOI: 10.1002/14651858.CD004622.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  11 in total

1.  Producing guidance for the management of patients with chronic periodontal disease in general dental practice.

Authors:  G Allen
Journal:  Br Dent J       Date:  2015-04-24       Impact factor: 1.626

2.  Evidence that full-mouth scaling superior to conventional treatment approaches is unclear.

Authors:  Mark McLaughlin; Brett Duane
Journal:  Evid Based Dent       Date:  2016-03

Review 3.  Full-mouth treatment modalities (within 24 hours) for periodontitis in adults.

Authors:  Pia-Merete Jervøe-Storm; Jörg Eberhard; Ian Needleman; Helen V Worthington; Søren Jepsen
Journal:  Cochrane Database Syst Rev       Date:  2022-06-28

Review 4.  Full-mouth treatment modalities (within 24 hours) for chronic periodontitis in adults.

Authors:  Joerg Eberhard; Sören Jepsen; Pia-Merete Jervøe-Storm; Ian Needleman; Helen V Worthington
Journal:  Cochrane Database Syst Rev       Date:  2015-04-17

5.  The Quality of the Evidence According to GRADE Is Predominantly Low or Very Low in Oral Health Systematic Reviews.

Authors:  Nikolaos Pandis; Padhraig S Fleming; Helen Worthington; Georgia Salanti
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

6.  Clinical Evaluation of the Efficacy of Arthocare Forte, a Chondro-Protective and Anti-Arthritic Drug in the Management of Bacterial Plaque-Induced Chronic Periodontitis.

Authors:  C E Anyanechi; F N Chukwuneke; N Ngim
Journal:  Ann Med Health Sci Res       Date:  2015 May-Jun

7.  The Effect of Nonsurgical Periodontal Therapy on Trichomonas Tenax and Entamoeba Gingivalis in Patients with Chronic Periodontitis.

Authors:  Fahimeh Rashidi Maybodi; Ahmad Haerian Ardakani; Ali Fattahi Bafghi; Alireza Haerian Ardakani; Akram Zafarbakhsh
Journal:  J Dent (Shiraz)       Date:  2016-09

Review 8.  Twenty Years of Full-Mouth Disinfection: The Past, the Present and the Future.

Authors:  Ange Désiré Pockpa; Assem Soueidan; Pauline Louis; Nadin Thérèse Coulibaly; Zahi Badran; Xavier Struillou
Journal:  Open Dent J       Date:  2018-05-31

9.  Treating chronic periodontitis: current status, challenges, and future directions.

Authors:  Luciana M Shaddox; Clay B Walker
Journal:  Clin Cosmet Investig Dent       Date:  2010-08-11

Review 10.  Historical and contemporary hypotheses on the development of oral diseases: are we there yet?

Authors:  Bob T Rosier; Marko De Jager; Egija Zaura; Bastiaan P Krom
Journal:  Front Cell Infect Microbiol       Date:  2014-07-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.